Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Investor Wire

CGEN Quote, Trading Chart, Compugen Ltd.


home / stock / cgen / cgen quote

$9.33 Last:

4.13% Change Percent:

$9.01 Open:

$9.33 Previous Close:

$9.43 High:

$8.5 Low:

3,244,460 Volume:

02/26/2021 04:55:25 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-02-269.019.339.438.53,244,460
2021-02-2510.838.9610.998.834,187,526
2021-02-2410.5110.3610.579.962,339,775
2021-02-2311.6810.5111.7103,043,428
2021-02-2213.3311.8213.3411.481,922,324
2021-02-1912.7412.7713.32512.735894,237
2021-02-1812.8412.5612.99121,095,866
2021-02-1713.0213.2113.4912.745911,649
2021-02-1613.4213.0813.8613.0351,180,716
2021-02-1512.8713.1313.2312.73643,856
2021-02-1212.8713.1313.2312.73643,747
2021-02-1113.1813.0113.387212.66706,280
2021-02-1013.9113.1314.0812.87778,177
2021-02-0913.8913.4714.1713.461,072,943
2021-02-0813.3713.771413.341,300,464
2021-02-0512.812.9713.1112.52766,353
2021-02-0412.9312.5313.312.48959,817
2021-02-0313.6712.8813.736212.87791,342
2021-02-0213.1513.4913.8813.151,305,907
2021-02-0112.4713.0413.1812.391,142,830
Stock Information

Compugen Ltd. Company Name:

CGEN Stock Symbol:

NASDAQ Market:

MENU
CGEN CGEN Quote CGEN Short CGEN News CGEN Articles CGEN Message Board
Get CGEN Alerts

News, Short Squeeze, Breakout and More Instantly...

Stock Investor Wire
RECENT CGEN NEWS
  • CGEN - Compugen Ltd. (CGEN) Q4 2020 Earnings Call Transcript

    Image source: The Motley Fool. Compugen Ltd. (NASDAQ: CGEN) Q4 2020 Earnings Call Feb 26, 2021 , 8:30 p.m. ET Operator Continue reading For further details see: Compugen Ltd. (CGEN) Q4 2020 Earnings Call Transcript

  • CGEN - Compugen Reports Fourth Quarter and Full Year 2020 Results

    Compugen Reports Fourth Quarter and Full Year 2020 Results Encouraging signals of anti-tumor activity demonstrated across COM701 Phase 1 combination and monotherapy studies with durable responses, including a complete response, in tumor types typically unresponsive to checkpoint...

  • CGEN - Compugen Announces Data Update from COM701 Phase 1 Clinical Trial

    Compugen Announces Data Update from COM701 Phase 1 Clinical Trial Durable responses observed with COM701 in combination with Opdivo® including a confirmed complete response in a patient with prior progression on Opdivo® COM701 monotherapy demonstrates signals of an...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.


Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News